Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Fortress Value Acquisition Corp. II was a special purpose acquisition company sponsored by Fortress Credit and formed to complete a merger or similar business combination. It completed its IPO in August 2020 and traded on the New York Stock Exchange under the symbols FAII, FAII.U, and FAII WS. In June 2021, the company completed its business combination with ATI Physical Therapy, after which the combined company began trading as ATI Physical Therapy under the symbol ATIP. Fortress Value Acquisition Corp. II did not itself operate a therapeutic, biotech, or healthcare product pipeline; it functioned as a financial vehicle for the de-SPAC transaction.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Fortress Value Acquisition Corp. II.